| Primary |
| Hypertension |
20.3% |
| Angina Pectoris |
13.5% |
| Cardiomyopathy |
12.2% |
| Electrocardiogram St Segment Depression |
5.4% |
| Ischaemic Cardiomyopathy |
5.4% |
| Sleep Disorder |
5.4% |
| Atrial Fibrillation |
4.1% |
| Brain Neoplasm |
4.1% |
| Cardiac Failure Congestive |
4.1% |
| Open Angle Glaucoma |
4.1% |
| Arthralgia |
2.7% |
| Back Pain |
2.7% |
| Coronary Artery Disease |
2.7% |
| Diabetes Mellitus Non-insulin-dependent |
2.7% |
| Memory Impairment |
2.7% |
| Spinal Compression Fracture |
2.7% |
| Abdominal Pain Upper |
1.4% |
| Acute Pulmonary Oedema |
1.4% |
| Analgesia |
1.4% |
| Confusional State |
1.4% |
|
| Uterine Hypotonus |
15.6% |
| Thyroid Neoplasm |
9.4% |
| White Blood Cell Count Decreased |
9.4% |
| Drug Ineffective |
6.3% |
| Pneumonia |
6.3% |
| Respiratory Arrest |
6.3% |
| Stress Echocardiogram |
6.3% |
| Blood Pressure Decreased |
3.1% |
| Bradycardia |
3.1% |
| Electrocardiogram Abnormal |
3.1% |
| Infarction |
3.1% |
| Injury |
3.1% |
| Jaundice |
3.1% |
| Memory Impairment |
3.1% |
| Migraine |
3.1% |
| Neonatal Disorder |
3.1% |
| Orthostatic Hypotension |
3.1% |
| Pancytopenia |
3.1% |
| Pneumonia Aspiration |
3.1% |
| Pyrexia |
3.1% |
|
| Secondary |
| Hypertension |
25.0% |
| Drug Use For Unknown Indication |
21.4% |
| Product Used For Unknown Indication |
10.8% |
| Essential Hypertension |
5.3% |
| Parkinson's Disease |
4.2% |
| Epilepsy |
3.6% |
| Angina Pectoris |
3.1% |
| Ischaemic Cardiomyopathy |
2.8% |
| Prophylaxis |
2.8% |
| Cardiovascular Event Prophylaxis |
2.5% |
| Hyperuricaemia |
2.5% |
| Coronary Artery Bypass |
2.2% |
| Hypothyroidism |
2.2% |
| Renal Failure Chronic |
2.2% |
| Myocardial Ischaemia |
1.9% |
| Cardiac Failure Congestive |
1.7% |
| Hypertensive Cardiomyopathy |
1.7% |
| Cardiac Failure |
1.4% |
| Depression |
1.4% |
| Diabetes Mellitus |
1.4% |
|
| Renal Failure |
13.0% |
| Hyperthyroidism |
11.7% |
| Orthostatic Hypotension |
10.4% |
| Malaise |
7.8% |
| Presyncope |
6.5% |
| Delirium |
5.2% |
| Pulmonary Alveolar Haemorrhage |
5.2% |
| Condition Aggravated |
3.9% |
| Fall |
3.9% |
| Rhabdomyolysis |
3.9% |
| Syncope |
3.9% |
| Vertigo |
3.9% |
| Aplastic Anaemia |
2.6% |
| Cardio-respiratory Arrest |
2.6% |
| Cerebral Haemorrhage |
2.6% |
| Hepatitis Fulminant |
2.6% |
| Hyponatraemia |
2.6% |
| Hypotension |
2.6% |
| Lichenoid Keratosis |
2.6% |
| Locked-in Syndrome |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
25.5% |
| Hypertension |
18.4% |
| Product Used For Unknown Indication |
12.5% |
| Angina Pectoris |
6.4% |
| Diabetes Mellitus |
4.0% |
| Constipation |
3.3% |
| Unevaluable Event |
3.0% |
| Cardiac Failure |
2.9% |
| Prophylaxis |
2.9% |
| Insomnia |
2.7% |
| Atrial Fibrillation |
2.6% |
| Pain |
2.0% |
| Gastritis |
1.9% |
| Non-small Cell Lung Cancer |
1.9% |
| Rheumatoid Arthritis |
1.8% |
| Acute Myocardial Infarction |
1.7% |
| Cerebral Infarction |
1.7% |
| Cardiac Failure Chronic |
1.6% |
| Thrombosis Prophylaxis |
1.5% |
| Myocardial Ischaemia |
1.5% |
|
| Vomiting |
11.3% |
| Renal Failure |
8.7% |
| Thrombocytopenia |
8.3% |
| Renal Failure Acute |
7.7% |
| Urinary Tract Infection |
6.0% |
| Anaemia |
5.3% |
| Rhabdomyolysis |
5.3% |
| Respiratory Failure |
4.7% |
| Hyponatraemia |
4.3% |
| Interstitial Lung Disease |
4.3% |
| Somnolence |
4.0% |
| Syncope |
4.0% |
| Myocardial Infarction |
3.7% |
| Pneumonia |
3.7% |
| Loss Of Consciousness |
3.3% |
| Renal Failure Chronic |
3.3% |
| Hypertension |
3.0% |
| International Normalised Ratio Increased |
3.0% |
| Pancytopenia |
3.0% |
| Platelet Count Decreased |
3.0% |
|
| Interacting |
| Hypertension |
61.5% |
| Myocardial Ischaemia |
15.4% |
| Chest Pain |
7.7% |
| Hypercholesterolaemia |
7.7% |
| Hypothyroidism |
7.7% |
|
| Malaise |
25.0% |
| Orthostatic Hypotension |
25.0% |
| Somnolence |
25.0% |
| Varicose Ulceration |
25.0% |
|
